Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Amlodipine Maleate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 437Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
    The decade's top 10 patent losses, worth a whopping $915B in lifetime sales

    17 Aug 2017

    // Eric Sagonowsky FIERCE PHARMA

    http://www.fiercepharma.com/pharma/decade-s-top-10-patent-losses-featuring-seismic-sales-shifts

    Eric Sagonowsky FIERCE PHARMA
    17 Aug 2017
    Share Share
    Will Gilead Follow The Pfizer Game Plan For Sales Growth?
    Will Gilead Follow The Pfizer Game Plan For Sales Growth?

    03 Feb 2016

    // John LaMattina FORBES

    http://www.forbes.com/sites/johnlamattina/2016/02/02/will-gilead-follow-the-pfizer-game-plan-for-sales-growth/?ss=pharma-healthcare#76f8d94819e0

    John LaMattina FORBES
    03 Feb 2016
    Share Share
    Kitov's combo arthritis drug clears Phase III with an FDA filing on deck
    Kitov's combo arthritis drug clears Phase III with an FDA filing on deck

    15 Dec 2015

    // Damian Garde FIERCE BIOTECH

    http://www.fiercebiotech.com/story/kitov-pharmas-combo-arthritis-drug-clears-phase-iii-fda-filing-deck/2015-12-15

    Damian Garde FIERCE BIOTECH
    15 Dec 2015
    Share Share